Literature DB >> 8244177

High-dose-rate brachytherapy in primary stage I and II vaginal cancer.

P J Nanavati1, J Fanning, R D Hilgers, J Hallstrom, D Crawford.   

Abstract

Thirteen patients with primary vaginal cancer were treated with external beam irradiation and high-dose-rate brachytherapy. Median age was 65 years old. Five tumors were stage I, 4 stage IIA, and 4 stage IIB. Twelve tumors were squamous and 11 were moderately or poorly differentiated. Median tumor diameter was 4 cm. Patients were treated with external beam irradiation (4500 cGy) and high-dose-rate brachytherapy (2000-2800 cGy in three to four fractions). All 13 patients had a complete response. Local control was achieved in 12 patients (92%) at a median follow-up of 2.6 years. No acute or chronic intestinal or bladder grade 3 or 4 toxicity was observed. Moderate to severe vaginal stenosis occurred in 6 patients (46%). Treatment of stage I and II primary vaginal cancer with external beam irradiation and high-dose-rate brachytherapy appears to produce a high response rate, local control, and survival with minimal complications.

Entities:  

Mesh:

Year:  1993        PMID: 8244177     DOI: 10.1006/gyno.1993.1248

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Definitive radiation therapy for invasive carcinoma of the vagina: impact of high-dose rate intracavitary brachytherapy.

Authors:  Tetsuo Nonaka; Yuko Nakayama; Nobutaka Mizoguchi; Ryo Onose; Hisamori Kato; Hiroki Nakayama
Journal:  Int J Clin Oncol       Date:  2012-02-07       Impact factor: 3.402

Review 2.  Vaginal cancer.

Authors:  Perry W Grigsby
Journal:  Curr Treat Options Oncol       Date:  2002-04

3.  Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate.

Authors:  Naoyuki Kanayama; Fumiaki Isohashi; Yasuo Yoshioka; Sungjae Baek; Masashi Chatani; Tadayuki Kotsuma; Eiichi Tanaka; Ken Yoshida; Yuji Seo; Osamu Suzuki; Seiji Mabuchi; Yasuhiko Shiki; Keiji Tatsumi; Tadashi Kimura; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2015-01-22       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.